In last trading session, Acasti Pharma Inc. (NASDAQ:ACST) saw 2,158,881 shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $0.21 trading at -$0.01 or -4.62% at ring of the bell on the day assigns it a market valuation of $20.04 Million. That closing price of ACST’s stock is at a discount of -1366.67% from its 52-week high price of $3.08 and is indicating a premium of 14.29% from its 52-week low price of $0.18. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.77 Million shares which gives us an average trading volume of 5.92 Million if we extend that period to 3-months.

For Acasti Pharma Inc. (ACST), analysts’ consensus is at an average recommendation of Overweight while assigning it a mean rating of 2. Splitting up the data highlights that, out of 3 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 1 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.16 in the current quarter.

Acasti Pharma Inc. (NASDAQ:ACST) trade information

In the face of being in the red today for losing -4.62%, in the last five days ACST remained trading in the green while hitting it’s week-highest on Wednesday, Oct 14 when the stock touched $0.226 price level, adding 8.72% to its value on the day. Acasti Pharma Inc.’s shares saw a change of -91.58% in year-to-date performance and have moved -0.58% in past 5-day. Acasti Pharma Inc. (NASDAQ:ACST) showed a performance of 3.15% in past 30-days. Number of shares sold short was 1.37 Million shares which calculate 0.23 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $1.26 to the stock, which implies a rise of 500% to its current value. Analysts have been projecting $0.25 as a low price target for the stock while placing it at a high target of $2.27. It follows that stock’s current price would jump +980.95% in reaching the projected high whereas dropping to the targeted low would mean a loss of 19.05% for stock’s current value.

Acasti Pharma Inc. (ACST) estimates and forecasts

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0% during past 5 years. In 2020, company’s earnings growth rate is likely to be around 30.3% while estimates for its earnings growth in next 5 years are of 0%